Metabolic implications of reduced heart-type fatty acid binding protein in insulin resistant cardiac muscle

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1782, Issue 10, 2008, Pages 586-592

  Shearer, Jane ^a   Fueger, Patrick T ^a   Wang, ZhiZhang ^a   Bracy, Deanna P ^a   Wasserman, David H ^a   Rottman, Jeffrey N ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fatty acid; Glucose; Hyperinsulinemic euglycemic clamp; Obesity

Indexed keywords

FATTY ACID; FATTY ACID BINDING PROTEIN; INSULIN; LONG CHAIN FATTY ACID; SODIUM CHLORIDE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BLOOD VESSEL CATHETERIZATION; CARDIOVASCULAR FUNCTION; CAROTID ARTERY; CONTROLLED STUDY; FEMALE; GENOTYPE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE UTILIZATION; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE METABOLISM; HEART SIZE; HEART STIMULATION; IN VIVO STUDY; INSULIN RESISTANCE; JUGULAR VEIN; LIPID DIET; LOW FAT DIET; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SYSTOLIC BLOOD PRESSURE; TRANSGENIC MOUSE; WEANING; WILD TYPE;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; DIET, FAT-RESTRICTED; DIETARY FATS; FATTY ACID-BINDING PROTEINS; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE CLAMP TECHNIQUE; HEART; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, TRANSGENIC; MYOCARDIUM; VENTRICULAR FUNCTION;

MUS;

EID: 52049115140     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2008.07.003     Document Type: Article

References (44)

1. Taegtmeyer H., McNulty P., and Young M.E. Adaptation and maladaptation of the heart in diabetes: Part I: general concepts. Circulation 105 (2002) 1727-1733
2. Young M.E., McNulty P., and Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms. Circulation 105 (2002) 1861-1870
3. Binas B., Danneberg H., McWhir J., Mullins L., and Clark A.J. Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization. FASEB. J. 13 (1999) 805-812
4. Bonen A., Benton C.R., Campbell S.E., Chabowski A., Clarke D.C., Han X.X., Glatz J.F., and Luiken J.J. Plasmalemmal fatty acid transport is regulated in heart and skeletal muscle by contraction, insulin and leptin, and in obesity and diabetes. Acta Physiol. Scand. 178 (2003) 347-356
5. Bonen A., Luiken J.J., and Glatz J.F. Regulation of fatty acid transport and membrane transporters in health and disease. Mol. Cell Biochem. 239 (2002) 181-192
6. Murphy E.J., Barcelo-Coblijn G., Binas B., and Glatz J.F. Heart fatty acid uptake is decreased in heart fatty acid-binding protein gene-ablated mice. J. Biol. Chem. 279 (2004) 34481-34488
7. Lehmann F., Haile S., Axen E., Medina C., Uppenberg J., Svensson S., Lundback T., Rondahl L., and Barf T. Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target. Bioorg. Med. Chem. Lett. 14 (2004) 4445-4448
8. Furuhashi M., Tuncman G., Gorgun C.Z., Makowski L., Atsumi G., Vaillancourt E., Kono K., Babaev V.R., Fazio S., Linton M.F., Sulsky R., Robl J.A., Parker R.A., and Hotamisligil G.S. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 447 (2007) 959
9. Shearer J., Fueger P.T., Bracy D.P., Wasserman D.H., and Rottman J.N. Partial gene deletion of heart-type fatty acid-binding protein limits the severity of dietary-induced insulin resistance. Diabetes 54 (2005) 3133-3139
10. Finck B.N. The role of the peroxisome proliferator-activated receptor alpha pathway in pathological remodeling of the diabetic heart. Curr. Opin. Clin. Nutr. Metab. Care 7 (2004) 391-396
11. Fueger P.T., Bracy D.P., Malabanan C.M., Pencek R.R., Granner D.K., and Wasserman D.H. Hexokinase II overexpression improves exercise-stimulated but not insulin-stimulated muscle glucose uptake in high-fat-fed C57BL/6J mice. Diabetes 53 (2004) 306-314
12. Severson D.L. Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes. Can. J. Physiol. Pharmacol. 82 (2004) 813-823
13. Exil V.J., Roberts R.L., Sims H., McLaughlin J.E., Malkin R.A., Gardner C.D., Ni G., Rottman J.N., and Strauss A.W. Very-long-chain acyl-coenzyme a dehydrogenase deficiency in mice. Circ. Res. 93 (2003) 448-455
14. Rottman J.N., Ni G., Khoo M., Wang Z., Zhang W., Anderson M.E., and Madu E.C. Temporal changes in ventricular function assessed echocardiographically in conscious and anesthetized mice. J. Am. Soc. Echocardiogr. 16 (2003) 1150-1157
15. Halseth A.E., Bracy D.P., and Wasserman D.H. Limitations to basal and insulin-stimulated skeletal muscle glucose uptake in the high-fat-fed rat. Am. J. Physiol. Endocrinol. Metab. 279 (2000) E1064-E1071
16. Fueger P.T., Bracy D.P., Malabanan C.M., Pencek R.R., and Wasserman D.H. Regulation of glucose uptake by the working muscle of conscious mice: distribution of control between transport and phosphorylation. Am. J. Physiol. Endocrinol. Metab. (2003) 309.2003
17. Morgan C.R., and Lazarow A. Immunoassay of pancreatic and plasma insulin following alloxan injection of rats. Diabetes 14 (1965) 669-671
18. Rottman J.N., Bracy D., Malabanan C., Yue Z., Clanton J., and Wasserman D.H. Contrasting effects of exercise and NOS inhibition on tissue-specific fatty acid and glucose uptake in mice. Am. J. Physiol. Endocrinol. Metab. 283 (2002) E116-E123
19. Furler S.M., Jenkins A.B., and Kraegen E.W. Effect of insulin on [3H]deoxy-D-glucose pharmacokinetics in the rat. Am. J. Physiol. 255 (1988) E806-E811
20. Kraegen E.W., James D.E., Jenkins A.B., and Chisholm D.J. Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. Am. J. Physiol. Endocrinol. Metab. 248 (1985) E353-E362
21. Coburn C.T., Knapp Jr. F.F., Febbraio M., Beets A.L., Silverstein R.L., and Abumrad N.A. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J. Biol. Chem. 275 (2000) 32523-32529
22. Murray A.J., Panagia M., Hauton D., Gibbons G.F., and Clarke K. Plasma free fatty acids and peroxisome proliferator-activated receptor alpha in the control of myocardial uncoupling protein levels. Diabetes 54 (2005) 3496-3502
23. Carley A.N., and Severson D.L. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim. Biophys. Acta 1734 (2005) 112-126
24. Carley A.N., Atkinson L.L., Bonen A., Harper M.E., Kunnathu S., Lopaschuk G.D., and Severson D.L. Mechanisms responsible for enhanced fatty acid utilization by perfused hearts from type 2 diabetic db/db mice. Arch. Physiol. Biochem. 113 (2007) 65-75
25. Lam A., and Lopaschuk G.D. Anti-anginal effects of partial fatty acid oxidation inhibitors. Curr. Opin. Pharmacol. 7 (2007) 179-185
26. Roden M. Blocking fatty acids' mystery tour: a therapy for metabolic syndrome?. Cell Metab. 6 (2007) 89-91
27. Hegarty B.D., Cooney G.J., Kraegen E.W., and Furler S.M. Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. Diabetes 51 (2002) 1477-1484
28. He J., Goodpaster B.H., and Kelley D.E. Effects of weight loss and physical activity on muscle lipid content and droplet size. Obes. Res. 12 (2004) 761-769
29. Malenfant P., Joanisse D.R., Theriault R., Goodpaster B.H., Kelley D.E., and Simoneau J.A. Fat content in individual muscle fibers of lean and obese subjects. Int. J. Obes. Relat. Metab. Disord. 25 (2001) 1316-1321
30. Malenfant P., Tremblay A., Doucet E., Imbeault P., Simoneau J.A., and Joanisse D.R. Elevated intramyocellular lipid concentration in obese subjects is not reduced after diet and exercise training. Am. J. Physiol. Endocrinol. Metab. 280 (2001) E632-E639
31. Coort S.L., Coumans W.A., Bonen A., van der Vusse G.J., Glatz J.F., and Luiken J.J. Divergent effects of rosiglitazone on protein-mediated fatty acid uptake in adipose and in muscle tissues of Zucker rats. J. Lipid Res. 46 (2005) 1295-1302
32. Luiken J.J., Koonen D.P., Coumans W.A., Pelsers M.M., Binas B., Bonen A., and Glatz J.F. Long-chain fatty acid uptake by skeletal muscle is impaired in homozygous, but not heterozygous, heart-type-FABP null mice. Lipids 38 (2003) 491-496
33. Glatz J.F., Schaap F.G., Binas B., Bonen A., van der Vusse G.J., and Luiken J.J. Cytoplasmic fatty acid-binding protein facilitates fatty acid utilization by skeletal muscle. Acta Physiol. Scand. 178 (2003) 367-371
34. Zimmerman A.W., and Veerkamp J.H. New insights into the structure and function of fatty acid-binding proteins. Cell Mol. Life Sci. 59 (2002) 1096-1116
35. Alaynick W.A., Kondo R.P., Xie W., He W., Dufour C.R., Downes M., Jonker J.W., Giles W., Naviaux R.K., Giguere V., and Evans R.M. ERRgamma directs and maintains the transition to oxidative metabolism in the postnatal heart. Cell Metab. 6 (2007) 13-24
36. Dufour C.R., Wilson B.J., Huss J.M., Kelly D.P., Alaynick W.A., Downes M., Evans R.M., Blanchette M., and Giguere V. Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma. Cell Metab. 5 (2007) 345-356
37. Heuckeroth R.O., Birkenmeier E.H., Levin M.S., and Gordon J.I. Analysis of the tissue-specific expression, developmental regulation, and linkage relationships of a rodent gene encoding heart fatty acid binding protein. J. Biol. Chem. 262 (1987) 9709-9717
38. Kempen K.P., Saris W.H., Kuipers H., Glatz J.F., and Van Der Vusse G.J. Skeletal muscle metabolic characteristics before and after energy restriction in human obesity: fibre type, enzymatic beta-oxidative capacity and fatty acid-binding protein content. Eur. J. Clin. Invest. 28 (1998) 1030-1037
39. Schmitt B., Fluck M., Decombaz J., Kreis R., Boesch C., Wittwer M., Graber F., Vogt M., Howald H., and Hoppeler H. Transcriptional adaptations of lipid metabolism in tibialis anterior muscle of endurance-trained athletes. Physiol. Genomics 15 (2003) 148-157
40. Yuan Y., Kwong A.W., Kaptein W.A., Fong C., Tse M., Glatz J.F., Chan C., and Renneberg R. The responses of fatty acid-binding protein and creatine kinase to acute and chronic exercise in junior rowers. Res. Q. Exerc. Sport 74 (2003) 277-283
41. Clavel S., Farout L., Briand M., Briand Y., and Jouanel P. Effect of endurance training and/or fish oil supplemented diet on cytoplasmic fatty acid binding protein in rat skeletal muscles and heart. Eur. J. Appl. Physiol. 87 (2002) 193-201
42. Hittel D., and Storey K.B. Differential expression of adipose- and heart-type fatty acid binding proteins in hibernating ground squirrels. Biochim. Biophys. Acta 1522 (2001) 238-243
43. Fueger P.T., Lee-Young R.S., Shearer J., Bracy D.P., Heikkinen S., Laakso M., Rottman J.N., and Wasserman D.H. Phosphorylation barriers to skeletal and cardiac muscle glucose uptakes in high-fat fed mice: studies in mice with a 50% reduction of hexokinase II. Diabetes 56 (2007) 2476-2484
44. Park S.Y., Cho Y.R., Kim H.J., Higashimori T., Danton C., Lee M.K., Dey A., Rothermel B., Kim Y.B., Kalinowski A., Russell K.S., and Kim J.K. Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. Diabetes 54 (2005) 3530-3540